Gianluca Canettieri
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Brain-Targeted Delivery of Phenformin Using Phospholipid and Non-Phospholipid Vesicles for SHH Medulloblastoma.
Journal: Nanomaterials (Basel, Switzerland)
Published: February 26, 2026
Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides.
Journal: Disease models & mechanisms
Published: November 03, 2025
Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 08, 2025
Opposite effects of spermidine and GC7 in cell culture are dictated by distinct molecular targets.
Journal: The Biochemical journal
Published: July 03, 2025
Partial truncation of the C-terminal domain of PTCH1 in cancer promotes tumourigenesis by non-canonical activation of a GLI-PI3K loop.
Journal: Oncogene
Published: June 11, 2025
Colorectal cancer chemoprevention: Exploring the path from molecular mechanisms to available drugs.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: May 27, 2025
Correction to "Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as Anticancer Agent".
Journal: ACS pharmacology & translational science
Published: March 08, 2025
MEX3A is a diagnostic, independent prognostic biomarker and a promising therapeutic target in glioblastoma.
Journal: Frontiers in oncology
Published: February 28, 2025
AMBRA1 enhances Sonic Hedgehog signaling during cerebellar development and in medulloblastoma.
Journal: Developmental cell
Published: February 13, 2025
Last Updated: 09/26/2026